Jaguar Health, Inc.
JAGX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 19.8% | -18.4% | 175.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 83.3% | 79.1% | 83.1% | 46.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -313.6% | -335.6% | -279.2% | -977.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -329.3% | -423.1% | -396.9% | -1,213.3% |
| EPS Diluted | -130.69 | -2,685 | -4,070,250 | -11,370,375 |
| % Growth | 95.1% | 99.9% | 64.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |